Real-world treat-to-target skin clearance with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry

被引：0
|
作者：
Armstrong, April W. [1 ]
Ferris, Laura K. [2 ]
Duffin, Kristina Callis [3 ]
Janak, Jud [4 ]
Sima, Adam [4 ]
Eckmann, Thomas [4 ]
Patel, Manish [5 ]
Photowala, Huzefa [5 ]
Garg, Vishvas [5 ]
Strober, Bruce [6 ,7 ]
机构：
[1] Univ Southern Calif, Los Angeles, CA 90007 USA
[2] Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15260 USA
[3] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA
[4] CorEvitas LLC, Waltham, MA USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Yale Univ, Sch Med, New Haven, CT 06520 USA
[7] Connecticut Dermatol, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34820
引用
收藏
页码：AB200 / AB200
页数：1
相关论文
共 50 条
  • [1] Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
    Armstrong, April W.
    Ferris, Laura K.
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Photowala, Huzefa
    Patel, Manish
    Garg, Vishvas
    Strober, Bruce E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [2] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [3] Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura K.
    Duffin, Kristina Callis
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [4] Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
    Robert R. McLean
    Adam P. Sima
    Silky Beaty
    Robert Low
    Rebecca L. Spitzer
    Jeffrey L. Stark
    Elizabeth Lesser
    Edward Lee
    April Armstrong
    [J]. Dermatology and Therapy, 2023, 13 : 2739 - 2751
  • [5] Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
    Mclean, Robert R.
    Sima, Adam P.
    Beaty, Silky
    Low, Robert
    Spitzer, Rebecca L.
    Stark, Jeffrey L.
    Lesser, Elizabeth
    Lee, Edward
    Armstrong, April
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2739 - 2751
  • [6] Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas' Psoriasis Registry
    Ogdie, Alexis
    Strober, Bruce
    Lebwohl, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB103 - AB103
  • [7] Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
    Mclean, Robert R.
    Sima, Adam P.
    Beaty, Silky
    Jones, Eric A.
    Eckmann, Thomas
    Low, Robert
    Mcclung, Laura
    Spitzer, Rebecca L.
    Stark, Jeffrey
    Armstrong, April
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2753 - 2768
  • [8] Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
    Robert R. McLean
    Adam P. Sima
    Silky Beaty
    Eric A. Jones
    Thomas Eckmann
    Robert Low
    Laura McClung
    Rebecca L. Spitzer
    Jeffrey Stark
    April Armstrong
    [J]. Dermatology and Therapy, 2023, 13 : 2753 - 2768
  • [9] Long Term Real-World Patient-Reported Outcomes with Risanki-zumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
    Strober, Bruce E.
    Ferris, Laura K.
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April W.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB189 - AB189
  • [10] Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
    April W. Armstrong
    Timothy Fitzgerald
    Robert R. McLean
    Amanda Teeple
    Jonathan P. Uy
    Mobolaji Olurinde
    Katelyn Rowland
    Lin Guo
    Ying Shan
    Kristina Callis Duffin
    [J]. Dermatology and Therapy, 2023, 13 : 629 - 640
12345